Rotor Syndrome: Causes, Symptoms, Diagnosis, and Treatment

Rotor syndrome is a rare hereditary condition characterized by chronically elevated bilirubin levels in the blood, primarily its conjugated fraction, resulting in intermittent or persistent yellowing of the skin and sclera. Signs of liver damage are typically absent: liver enzymes remain normal, and there is no inflammation, cholestasis, or progressive fibrosis. From a practical standpoint, this is a "benign" cause of jaundice, which is important to recognize to avoid unnecessary and sometimes traumatic examinations. [1]

In modern understanding, Rotor syndrome refers to a disorder of hepatic bilirubin transport: the liver is less able to capture and "return" conjugated bilirubin from the blood. This distinguishes Rotor syndrome from hepatitis, cholelithiasis with bile duct obstruction, and many other causes of jaundice involving inflammation or mechanical obstruction of bile flow. Therefore, the physician's key task is to confirm the typical laboratory profile and rule out dangerous causes of jaundice. [2]

Rotor syndrome often begins in childhood, but may also be first detected in adulthood during tests for other reasons. Jaundice often worsens during infections, stress, sleep deprivation, certain medications, or hormonal fluctuations, but overall, the course remains stable. In many people, the only symptom is mild yellowing of the sclera without any other complaints. [3]

In everyday medicine, Rotor syndrome is important as a "diagnosis-explanation": it helps calmly interpret chronically elevated bilirubin levels with otherwise normal parameters. With a confirmed diagnosis, treatment is usually not required, and the primary focus shifts to patient education, medication safety testing, and prudent monitoring. [4]

Code according to ICD-10 and ICD-11

In the International Classification of Diseases, 10th revision (ICD-10), Rotor syndrome is typically classified under the category "Other disorders of bilirubin metabolism," where it is listed as an inclusion. In practice, this means that documentation often uses a code for a group of bilirubin metabolism disorders rather than a separate, unique category specifically for Rotor syndrome. [5]

In the International Classification of Diseases, 11th revision (ICD-11), Rotor syndrome is also included in the group of disorders of bilirubin metabolism or excretion and is usually coded as "other specified disorders" of this group. It is important to note that the specific code choice in actual reporting may depend on the coding rules in the country and on how the diagnosis is formulated in the discharge summary, but the assignment to the "disorders of bilirubin metabolism" group remains the same. [6]

Table 1. ICD-10 and ICD-11 codes for Rotor syndrome

Classification	Heading	Code	As is usually formulated
ICD-10	Other disorders of bilirubin metabolism	E80.6	"Rotor Syndrome" as an inclusion in the rubric
ICD-11	Other specified disorders of bilirubin metabolism or excretion	5C58.0Y	Rotor type hyperbilirubinemia

Sources of codes and inclusions are given in the official ICD-10 browser and in the ICD-11 reference cards, as well as in specialized catalogs of rare diseases. [7]

Epidemiology

Rotor syndrome is a very rare condition: its prevalence is considered extremely low, less than 1 case per 1,000,000 people. For physicians, this means that the diagnosis is rare in the general population, but in the office of a gastroenterologist or hepatologist, it may be encountered when examining persistent conjugated hyperbilirubinemia without signs of liver damage. [8]

According to rare disease reviews, the number of confirmed cases described in the literature is limited, making precise incidence and prevalence estimates difficult. Genetic studies of populations are proving most informative, identifying common carrier variants that could potentially increase the incidence of the syndrome in certain regions. [9]

A high carrier frequency of one of the pathogenic variants in the organic anion transporter 1B3 (SLCO1B3) gene has been described for some East Asian populations; however, the disease itself develops only with a combined defect of both organic anion transporter 1B1 (SLCO1B1) and organic anion transporter 1B3 (SLCO1B3). Therefore, a high carrier frequency does not equate to a high prevalence of the disease, but it does suggest where the syndrome may be relatively more common. [10]

From a practical perspective, the epidemiology of Rotor syndrome is important for families with consanguineous marriages or recurrent cases of unexplained jaundice in relatives. In such situations, the likelihood of a hereditary mechanism is higher, and the diagnostic strategy shifts toward confirming the characteristic biochemical profile and molecular genetic testing. [11]

Reasons

The immediate cause of Rotor syndrome is a congenital defect in the liver transport proteins responsible for transporting certain substances from the blood into the liver. The key proteins are organic anion transporter 1B1 (SLCO1B1) and organic anion transporter 1B3 (SLCO1B3): in Rotor syndrome, the function of both is impaired, resulting in a typical bilirubin profile. [12]

Inheritance is described as autosomal recessive with a digenic mechanism: pathogenic variants in both genes are required for the disease to develop, and in the presence of at least one "active" allele of one of these genes, clinically significant hyperbilirubinemia typically does not develop. This is an important difference from many "common" autosomal recessive diseases, where a single gene determines almost everything. [13]

The cause of jaundice is not increased red blood cell destruction or bile duct obstruction, but a disruption in bilirubin transport at the hepatocyte level. Therefore, examination usually reveals no anemia, no elevated liver enzymes, and no signs of cholestasis, with conjugated bilirubin dominating the analysis. [14]

In real-world clinical practice, the "cause" is sometimes formulated as "congenital bilirubin metabolism disorder" until the diagnosis is confirmed genetically. This is acceptable initially, but for a final conclusion, the most convincing are characteristic hepatobiliary scintigraphy data and the detection of pathogenic variants in SLCO1B1 and SLCO1B3. [15]

Risk factors

The main risk factor is family history: cases of unexplained jaundice in siblings or other relatives, especially since childhood, with normal liver tests. Consanguinity of parents is especially important because it increases the chance of inheriting the same pathogenic variants. [16]

The population risk factor is associated with the carriage frequency of individual pathogenic variants in certain ethnic groups. For example, variants with high carriage frequency have been described for some East Asian populations, but the disease remains rare, as it requires a combined defect of two genes. [17]

Factors that do not "cause" the syndrome but make jaundice more noticeable include intercurrent infections, severe stress, sleep deprivation, dehydration, and sometimes medications that affect hepatic transport. These triggers more often increase scleral yellowness than lead to any dangerous complications. [18]

A separate clinical risk group consists of individuals prescribed drugs that are actively taken up by the liver via organic anion transporters 1B1 and 1B3. Even though severe drug reactions in Rotor syndrome are rarely documented, altered pharmacokinetics are theoretically possible, so a drug history and careful selection of therapy are important. [19]

Pathogenesis

Normally, bilirubin, after being processed in the liver, becomes conjugated and is excreted in bile, and some of the conjugated bilirubin may return from the blood to the liver. In Rotor syndrome, the hepatic uptake of certain organic anions from the blood is impaired, including components associated with bilirubin metabolism. [20]

When organic anion transporters 1B1 and 1B3 are dysfunctional, the liver is less able to reabsorb conjugated bilirubin from sinusoidal blood and less able to retain it intrahepatically. As a result, conjugated bilirubin accumulates in the blood, bilirubin appears in the urine, and the stool usually does not become discolored because there is no significant mechanical blockage of the bile ducts. [21]

A characteristic diagnostic marker of pathogenesis is a change in the urinary porphyrin profile: total coproporphyrin levels increase approximately 2.5-5 times, reflecting the characteristics of hepatic transport of organic anions. This is not absolutely specific, but in combination with other signs, it helps distinguish Rotor syndrome from other conditions. [22]

Also typical of hepatobiliary scintigraphy are the following: the radiopharmaceutical is slowly taken up by the liver, the liver is poorly visualized, while the "blood pool" remains visible for a long time, and excretion through the kidneys becomes noticeable. This is not just a "picture," but functional confirmation that the problem lies in uptake and intrahepatic transport, not in liver cell destruction. [23]

Symptoms

The most common and often the only symptom is jaundice: a yellowing of the sclera and sometimes the skin. It can be constant or episodic, and its severity often fluctuates throughout life. For many people, it is a cosmetic feature rather than a sign of a serious illness. [24]

General well-being, appetite, and exercise tolerance are usually maintained; fever and itching, as seen with severe cholestasis, are usually absent. If severe itching is present, this suggests another cause of jaundice, as the absence of cholestasis and liver damage is typical of Rotor syndrome. [25]

On examination, the liver is usually not enlarged or is only minimally enlarged, and the "liver signs" of chronic liver disease are absent. The spleen is usually normal in size, there is no swelling, and there is no bleeding. It is the discrepancy between visible jaundice and the "normal" appearance of the rest of the examination that often leads the physician to suspect benign hereditary hyperbilirubinemia. [26]

In laboratory tests, even when jaundice is noticeable, liver enzymes are usually within normal limits, and bilirubin is moderately elevated, often in the range of about 2-5 milligrams per deciliter, although rare higher values have been reported. Bilirubin is detected in urine, which may cause it to darken, but this is not accompanied by a deterioration in liver function. [27]

Table 2. Typical laboratory profile in Rotor syndrome

Indicator	Typical for Rotor syndrome	What does this mean clinically?
Total bilirubin	more often 2-5 milligrams per deciliter	moderate hyperbilirubinemia
The proportion of conjugated bilirubin	more than 50% of the total	predominance of the conjugated fraction
Alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, gamma-glutamyl transferase	usually normal	no liver damage or severe cholestasis
Signs of hemolysis	are absent	jaundice is not associated with the destruction of red blood cells
Bilirubin in urine	is revealed	confirms conjugated hyperbilirubinemia
Coproporphyrins in urine	an increase of approximately 2.5-5 times	auxiliary transport violation marker

Threshold values and general profile are given in modern reviews on Rotor syndrome.[28]

Classification, forms and stages

There is no single "official" staging system for Rotor syndrome, as the disease does not progress like chronic hepatitis and does not lead to cirrhosis. However, in clinical descriptions, it is convenient to distinguish between variants based on the nature of the disease: constant jaundice and intermittent jaundice, when periods of normal scleral color alternate with exacerbations. This helps explain to the patient why indicators can fluctuate without worsening the prognosis. [29]

The forms are also conventionally distinguished by age of detection: early detection in childhood and late detection in adulthood. This difference is often associated not with different disease biology, but with when fractional bilirubin was first measured and other causes of jaundice were ruled out. In both cases, the laboratory data profile is usually the same. [30]

Another practical approach is to assess the bilirubin level: mild cases (moderate elevation, usually 2-5 milligrams per deciliter) and rare cases with higher values. Importantly, even higher values do not in themselves indicate liver damage if other indicators remain normal and the diagnosis is confirmed. [31]

From a genetic perspective, we can talk about "variants" based on the type of mutation: point changes and large deletions affecting regions of the SLCO1B1 and SLCO1B3 genes. For the patient, this is important primarily in the context of family counseling and the choice of genetic testing method, since some technologies are better at detecting point variations, while others are better at detecting large rearrangements. [32]

Complications and consequences

Rotor syndrome itself does not typically cause liver failure, portal hypertension, progressive fibrosis, or shorten life expectancy. The main "danger" is often organizational: jaundice is mistaken for a sign of a serious illness, leading to a long series of tests, including invasive procedures, which, with proper diagnosis, are often unnecessary. [33]

Psychological consequences are more common than medical ones: anxiety due to "yellow eyes," stigmatization, fear of hepatitis, and unreasonable limitations in work and sports. Therefore, part of the management is a clear explanation that confirmed Rotor syndrome is a benign condition. [34]

A potentially significant area is drug safety. Although severe adverse reactions specifically related to Rotor syndrome are rarely described, the absence of organic anion transporters 1B1 and 1B3 could theoretically alter the liver uptake and toxicity of certain drugs. Therefore, when prescribing certain medications, greater attention to dosage, interactions, and monitoring is required. [35]

Occasionally, during long-term observation, associated findings, such as gallstones, are discussed, but a clear causal relationship with Rotor syndrome is usually not proven. If pain, fever, severe itching, or a noticeable deterioration in liver function tests develop, this should be considered a separate problem and investigated outside the scope of the "usual" syndrome. [36]

When to see a doctor

A visit to the doctor is essential for any new-onset jaundice, especially if it is accompanied by weakness, fever, pain in the right upper quadrant, nausea, loss of appetite, or severe itching. These symptoms often indicate liver inflammation, cholestasis, or an infectious process, rather than benign hereditary hyperbilirubinemia. [37]

Urgent evaluation is necessary if jaundice is accompanied by dark urine and noticeably lighter stools, as this may indicate a disruption in the flow of bile into the intestines. Rotor syndrome is characterized by bilirubinuria, but discolored stools and progressive pain require the exclusion of mechanical biliary obstruction. [38]

Even if you already have Rotor syndrome, you should consult a doctor if new symptoms that weren't present before appear: persistent itching, weight loss, fever, bleeding, swelling, or severe weakness. These signs are not typical of Rotor syndrome and require a search for another cause, including liver disease, bile duct disease, or systemic conditions. [39]

Special considerations for consultation include pregnancy planning, major surgery, and starting long-term therapy with medications that are actively transported to the liver. In most cases, no special restrictions are required, but it is helpful to discuss test interpretation and medication management in advance to avoid confusing the characteristics of Rotor syndrome with pregnancy complications or side effects. [40]

Diagnostics

Diagnosis begins with confirming the type of jaundice: total bilirubin and its fractions are measured to determine whether conjugated bilirubin predominates. In parallel, indicators of liver damage and cholestasis are assessed: alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, gamma-glutamyl transferase, as well as total protein and albumin. Rotor syndrome typically combines conjugated hyperbilirubinemia with normal enzymes. [41]

The next step is to rule out hemolysis, because when red blood cells are destroyed, bilirubin increases via a different mechanism. Typically, a complete blood count, reticulocytes, lactate dehydrogenase, haptoglobin, and, if necessary, a direct Coombs test are assessed, and a blood smear is also examined. In Rotor syndrome, there are no signs of hemolysis, and this is an important early "filter." [42]

At the same time, common liver and biliary tract diseases are excluded: viral hepatitis, autoimmune processes, and metabolic disorders. The set of tests is selected based on the clinical situation, but the essence is the same: in Rotor syndrome, there should be no markers of active liver inflammation or progressive cholestasis. At this stage, an ultrasound examination of the liver and gallbladder is often performed to rule out bile duct dilation and gross structural changes. [43]

Next, we move on to tests that specifically support the diagnosis of Rotor syndrome. One of the most useful is a urine porphyrin analysis with coproporphyrin assessment, as total coproporphyrin levels are often elevated in Rotor syndrome, and the isomer ratio helps differentiate it from Dubin-Johnson syndrome. Another modern method of functional confirmation is hepatobiliary scintigraphy, which reveals a typical pattern of delayed liver uptake and pronounced renal elimination. [44]

Definitive confirmation is increasingly achieved through molecular genetic testing, which identifies pathogenic variants in SLCO1B1 and SLCO1B3. It is important to choose a method that detects not only point variants but also deletions and duplications, as large rearrangements are common. This approach avoids outdated dye tests, which were historically used but are now much less common due to their limited practical value and the availability of genetic data. [45]

Table 3. Step-by-step diagnostic algorithm for suspected Rotor syndrome

Step	What are they doing?	What is confirmed or excluded?
1	Bilirubin fractions	conjugated hyperbilirubinemia
2	Liver enzymes and cholestasis markers	absence of liver damage and severe cholestasis
3	Hemolysis markers	exclusion of hemolytic anemia
4	Ultrasound examination	exclusion of obstruction and gross pathology
5	Urinary porphyrins, coproporphyrins and isomers	support of diagnosis, differentiation from Dubin Johnson syndrome
6	Hepatobiliary scintigraphy	functional confirmation of liver uptake defect
7	Genetic testing for SLCO1B1 and SLCO1B3	final confirmation

The algorithm reflects modern diagnostic logic based on clinical reviews and GeneReviews. [46]

Differential diagnosis

A key "twin" of Rotor syndrome is Dubin-Johnson syndrome, which also presents with benign conjugated hyperbilirubinemia with normal liver enzymes. The difference lies in the mechanism: in Dubin-Johnson syndrome, bilirubin secretion into bile is impaired, while in Rotor syndrome, it is the uptake and intrahepatic transport of bilirubin from the blood. Clinically, both conditions appear similar, so laboratory and functional tests are used to determine the diagnosis. [47]

Among the "dangerous" causes of conjugated hyperbilirubinemia, biliary obstruction, acute and chronic hepatitis, autoimmune liver diseases, and cholangitis are primarily excluded. Here, the focus is on elevated alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, and gamma-glutamyl transferase, along with symptoms of intoxication and imaging data. In Rotor syndrome, these markers typically do not "confirm the disease" but remain normal, which helps to differentiate between serious pathologies. [48]

Other inherited disorders of bilirubin metabolism are also considered, but they often produce a different profile. Gilbert syndrome and Crigler-Najjar syndrome are usually associated with unconjugated bilirubin, while in Rotor syndrome, the conjugated component predominates. Therefore, bilirubin fractionation is a simple yet highly informative step that immediately narrows the differential search. [49]

If jaundice is accompanied by itching, elevated alkaline phosphatase and gamma-glutamyl transferase, duct dilation, or pain, the focus shifts to cholestatic diseases and gallstones. In such scenarios, a diagnosis of Rotor syndrome without fully ruling out obstruction is considered premature, as Rotor syndrome is characterized by isolated hyperbilirubinemia without cholestasis or liver damage. [50]

Table 4. How to distinguish Rotor syndrome from common alternatives

State	Type of bilirubin	Liver enzymes	Key distinguishing feature
Rotor syndrome	conjugated more than 50%	usually normal	Elevated urinary coproporphyrins, typical scintigraphy, SLCO1B1 and SLCO1B3 variants
Dubin Johnson syndrome	conjugated more than 50%	usually normal	the coproporphyrin profile is different, scintigraphy has other features
Viral or toxic hepatitis	often mixed	alanine aminotransferase and aspartate aminotransferase are elevated	signs of liver inflammation, corresponding markers
Biliary obstruction	conjugated	alkaline phosphatase and gamma-glutamyl transferase are often elevated	dilation of the ducts on visualization, light-colored stool, itching
Gilbert's syndrome	unconjugated	norm	unconjugated hyperbilirubinemia, other genetic markers

Comparative criteria and laboratory benchmarks are provided in modern reviews and in GeneReviews. [51]

Treatment

Specific treatment for Rotor syndrome is usually not required because the condition does not cause liver damage or worsen the prognosis. The most important treatment measure is an accurate diagnosis and clarification of the benign nature of the jaundice to avoid unnecessary repeated examinations and anxiety. This is especially important for adolescents and adults, for whom the cosmetic appearance of jaundice can be distressing. [52]

Once the diagnosis is confirmed, the primary approach is clinical observation rather than "treatment based on bilirubin levels." If all other parameters other than bilirubin are stable, periodic monitoring of blood chemistry is sufficient, especially when medications are changed or new symptoms appear. Any abnormal liver enzymes require a reassessment of the treatment strategy, as this is no longer typical of Rotor syndrome. [53]

In everyday life, basic measures that reduce the likelihood of noticeable fluctuations in jaundice are usually sufficient: regular sleep, adequate fluid intake, and avoiding prolonged fasting and dehydration during infections. These measures do not "correct" the genetic defect, but they do help reduce the severity of external manifestations in some people. However, Rotor syndrome does not require strict diets, detox programs, or "choleretic regimens." [54]

A major practical area of treatment is drug safety. In Rotor syndrome, the organic anion transporters 1B1 and 1B3 are absent, and many common drugs and their metabolites enter the liver through them. This means that when prescribing certain medications, it is prudent to assess the risk of interactions, start with the lowest effective doses, and, if necessary, monitor tolerance and biochemical parameters more frequently. [55]

Drugs that are particularly frequently discussed in the context of transport via SLCO1B1 and SLCO1B3 include some statins, ezetimibe, rifampin, certain anticancer drugs, some sartans, and a number of other medications. This does not mean a ban, but it does mean that informed choice is necessary: taking into account concomitant diseases, other medications, and potential inhibitors of hepatic transport. If muscle pain, severe weakness, nausea, or a sudden deterioration in blood tests occurs during therapy, an unscheduled evaluation is required. [56]

Sometimes patients are mistakenly prescribed "hepatoprotectors" and other medications "to lower bilirubin." There is no convincing evidence of the benefit of such approaches in Rotor syndrome, as the problem is not inflammation or toxic liver damage. If the medication is prescribed for another reason, it may be taken, but one should not expect such medications to "cure the syndrome." [57]

Pregnancy is a special situation. There are generally no specific obstetric restrictions due to Rotor syndrome, but elevated bilirubin can interfere with the interpretation of test results if intrahepatic cholestasis of pregnancy and other gestational liver diseases are suspected. Therefore, the appearance of itching, pain, or elevated liver enzymes requires evaluation as a "new condition," rather than attributing everything to Rotor syndrome. [58]

When planning surgeries and anesthesia, Rotor syndrome typically does not pose additional risks if liver function is intact and there is no other pathology. However, it is useful for the anesthesiologist to know the diagnosis in advance to correctly interpret bilirubin levels and more carefully select medications actively transported by the liver. This reduces the risk of "diagnostic panic" in the postoperative period due to habitually elevated bilirubin. [59]

In a family context, "treatment" includes genetic counseling: the inheritance mechanism and the likelihood of recurrence in children are explained, depending on the partner's status. If the family so desires, carrier testing of relatives is possible if family variants are known, but in most cases, the issue is one of informed decision-making rather than medical necessity, as the condition is benign. [60]

Modern "new methods" of treatment involve diagnostic accuracy rather than medication: broad gene panels, exome sequencing, and large deletion analysis allow for faster diagnosis and avoidance of liver biopsies and outdated functional tests. Clinical trials for rare diseases are being discussed in the scientific community, but for Rotor syndrome, active therapeutic trials may not be feasible in most cases due to its benign course. [61]

Table 5. Drug classes worth discussing with your doctor for Rotor syndrome

Group	Examples of international nonproprietary names	Why is it important?
Statins	simvastatin, atorvastatin, pravastatin, pitavastatin, rosuvastatin	altered hepatic delivery and tolerability may occur
Hypolipidemic agents	ezetimibe	participation of hepatic transport
Antibiotics	rifampicin	affects the transport and metabolism of a number of substances
Antitumor	methotrexate, irinotecan, cabazitaxel, some tyrosine kinase inhibitors	potential changes in pharmacokinetics and toxicity
Cardiovascular	olmesartan, valsartan, torsemide	some drugs depend on hepatic uptake
Others	mycophenolic acid, fexofenadine, cyclosporine	possible transport interactions

The list is based on reviews of transport via SLCO1B1 and SLCO1B3 provided in GeneReviews.[62]

Prevention

Since Rotor syndrome is genetic, there is no "prevention" as such, but there are measures to prevent complications from diagnosis and treatment. The primary measure is early recognition of the typical profile: isolated conjugated hyperbilirubinemia without cholestasis or liver damage. This helps avoid unnecessary interventions and reduces anxiety. [63]

Family prevention includes genetic counseling, especially if there is a history of childhood jaundice in the family or consanguineous marriages. Risks to offspring, options for partner testing, and the value of testing relatives are discussed. Even if genetic testing is not considered, it is helpful to document the diagnosis in medical records so that it can be taken into account in the future. [64]

Preventing drug-related problems involves regularly reviewing medications and alerting treating physicians to the diagnosis. Ideally, before initiating long-term therapy with drugs from "sensitive" groups, potential interactions are assessed and tolerance monitoring is planned. This is especially important when combining several medications and in the presence of concomitant diseases. [65]

General healthy lifestyle measures apply to everyone: moderate alcohol consumption or abstinence, weight control, regular vaccinations, and prompt treatment of infections. These measures do not cure Rotor syndrome, but they do reduce the likelihood of developing a "second" liver disease, which can alter enzyme activity and prognosis. [66]

Forecast

The prognosis for Rotor syndrome is favorable: the condition is considered benign and is not associated with increased mortality. Liver function is preserved, and quality of life is primarily determined by the extent to which the patient is affected by cosmetic jaundice and the effectiveness of medical care. [67]

Jaundice can persist for life, but most often remains mild or moderate. Fluctuations in bilirubin levels are possible and do not in themselves indicate deterioration if liver enzymes and other indicators are stable. Therefore, the prognosis largely depends on the correct interpretation of tests and the avoidance of "overtreatment." [68]

If signs of another liver or biliary disease appear in the future, the prognosis will depend on this new cause, not on Rotor syndrome. For this reason, it's important not to become so accustomed to jaundice that you ignore new symptoms or elevated liver enzymes. The rule is simple: Rotor syndrome explains bilirubin, but it shouldn't explain everything. [69]

Table 6. Forecast and observation

Question	Typical response in confirmed Rotor syndrome
Life expectancy	usually normal
Risk of cirrhosis and liver failure	not typical
Are permanent medications necessary?	usually not
Are regular check-ups necessary?	Depending on the situation, more often periodic monitoring of biochemistry
When to reconsider the diagnosis	if new symptoms appear or liver enzymes increase

The prognosis assessment is consistent with contemporary clinical reviews on Rotor syndrome.[70]

FAQ

Is Rotor syndrome contagious?
No, it is an inherited condition, not an infection or viral hepatitis. It is associated with genetic variants in SLCO1B1 and SLCO1B3 and is passed down through families in an autosomal recessive manner. [71]

Is it necessary to lower bilirubin by any means?
Usually not, because elevated bilirubin in Rotor syndrome does not reflect liver damage. It is more important to ensure that liver enzymes are normal and there is no other cause of jaundice. [72]

Is it possible to play sports and work without restrictions?
In most cases, yes, because Rotor syndrome does not reduce the body's functional capabilities. Limitations only arise in the case of other conditions not directly related to Rotor syndrome. [73]

How accurate is genetic testing?
It is considered confirmatory if pathogenic variants are detected in both the SLCO1B1 and SLCO1B3 genes, and it is important to use methods that detect both point changes and large deletions. This approach is especially useful if hepatobiliary scintigraphy is unavailable or undesirable. [74]

What should you do if your bilirubin levels are higher than usual?
First, evaluate your liver enzymes, cholestasis markers, and symptoms such as itching, pain, fever, and stool color changes. If atypical symptoms appear or liver enzymes increase, this is a reason to look for another cause rather than simply attribute it to Rotor syndrome. [75]

Key points from guidelines and expert opinions

"No treatment required." This is the baseline position statement for GeneReviews on Rotor syndrome, which is regularly updated and used as a professional reference for rare hereditary conditions. Authors: Professor Milan Jirsa, MD, PhD, specialist in clinical biochemistry and genetics, director of experimental hepatology research, Institute of Clinical and Experimental Medicine, Prague, Czech Republic, and co-authors. [76]

"Adverse drug effects are not documented, but the absence of liver proteins may have serious implications for drug uptake and toxicity." This is a practical statement for the real-world clinic: the diagnosis does not require therapy, but caution is required when prescribing certain medications. Source: GeneReviews, authors Milan Jirsa, Alasdair Kniseli, Alfred Schinkel, Stanislav Kmoch, updated 27.02.2025. [77]

"There are no known specific pregnancy management issues related to this syndrome, but hyperbilirubinemia may complicate the diagnosis of liver disease in pregnant women." This point is important to avoid missing intrahepatic cholestasis of pregnancy and other conditions that require specific management. Source: GeneReviews, a collaborative effort with clinical and research centers in the Czech Republic, Austria, and the Netherlands. [78]

"A diagnosis is important to reassure the patient and avoid unnecessary invasive and costly procedures." This is already the position of clinical practice from a publication demonstrating how extensive genetic testing helps distinguish Rotor syndrome from Dubin Johnson syndrome with similar clinical presentations. The authors emphasize the value of accurate diagnosis and avoiding unnecessary interventions. [79]